Elsevier and the International Society for Neurovascular Disease Partner on Co-branded Neurovascular Disease Book Series

Agreement calls for publication of one-to-two books per year, both edited volumes and monographs


Cambridge, MA, September 29, 2016

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it has partnered with the International Society for Neurovascular Disease (ISNVD) to develop and publish an ISNVD-cobranded series of books covering various topics in neurovascular disease. The book series will focus on the latest research in diagnostic and therapeutic modalities for neurovascular disease and its underlying cellular and molecular mechanisms.

“We are thrilled to partner with the ISNVD on a book series that will bring top research in neurovascular disease to the global community,” said Melanie Tucker, Senior Acquisitions Editor, Elsevier. “We look forward to a long and fruitful collaboration.”

Elsevier and the ISNVD agreed to publish one-to-two books per year, including both edited volumes and monographs on specific topics in neurovascular disease. The co-branded books will range from 300 to 500 pages each, with 15 to 25 chapters. The final published books will be available in both print and electronic formats, and hosted on Elsevier’s ScienceDirect.

"We are delighted to announce that the ISNVD has joined forces with Elsevier to produce a series of books on key topics, including those that were discussed in the ISNVD 2016 meeting in New York,” noted J. Steve Alexander, President, ISNVD. “The books will cover various aspects of neurological diseases and beyond.”

---

Note for editors
E-book review copies of the new books will be available to credentialed journalists upon request. Contact Jelena Baras at sciencereviewcopies@elsevier.com.

About ISNVD
The International Society for Neurovascular Disease is a non-profit professional association established in 2010. The ISNVD is dedicated to the dissemination and review of new concepts in etiopathogenesis, novel diagnostics and modes of therapeutic treatment in the diseases of the neurovasculature. One of their main goals is to promote communication, research, development, applications, publications and the availability of information on neurovascular and related neurodegenerative diseases such as multiple sclerosis internationally. Their Executive Committee is comprised of many of the leading researchers and clinicians in the field. The Society holds an annual scientific meeting and sponsors educational and scientific workshops. Members are mostly researchers and clinicians in neurology, neurosurgery, vascular surgery, and interventional radiology. https://isnvd.org

About Elsevier
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com

Media contact
Pam Foote
Publicity Team, Science & Technology Books, Elsevier
+1 978 691 5572
footep@reedelsevier.com